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Abstract 20 
It is currently unknown whether the molecular steps of large dense-core vesicle 21 
(LDCV) docking and priming are identical to the corresponding reactions in synaptic 22 
vesicle (SV) exocytosis. Munc13s are essential for SV docking and priming, and we 23 
systematically analyzed their role in LDCV exocytosis using chromaffin cells lacking 24 
individual isoforms. We show that particularly Munc13-2 plays a fundamental role in 25 
LDCV exocytosis, but in contrast to synapses lacking Munc13s, the corresponding 26 
chromaffin cells do not exhibit a vesicle docking defect. We further demonstrate that 27 
ubMunc13-2 and Munc13-1 confer Ca2+-dependent LDCV priming with similar 28 
affinities, but distinct kinetics. Using a mathematical model, we identify an early 29 
LDCV priming step that is strongly dependent upon Munc13s. Our data demonstrate 30 
that the molecular steps of SV and LDCV priming are very similar while SV and 31 
LDCV docking mechanisms are distinct. 32 
  33 
 3
Introduction 34 
The regulated, Ca2+-triggered secretion of catecholamines from chromaffin cell 35 
LDCVs is an integral part of the physiological adaption to environmental stressors. 36 
Like the exocytosis of neuronal SVs, LDCV exocytosis is mediated by SNARE 37 
complex formation, in concert with Ca2+ sensors and essential regulatory proteins 38 
(James and Martin, 2013; Neher, 2006; Ovsepian and Dolly, 2011; Pang and Sudhof, 39 
2010). 40 
Mammalian uncoordinated 13 (Munc13) proteins are essential SV priming factors in 41 
neurons (Augustin et al., 1999; Richmond et al., 1999; Rosenmund et al., 2002), and 42 
ultrastructural studies have shown that in synapses lacking Munc13s/Unc-13, SVs 43 
also fail to physically dock to synaptic active zones (Imig et al., 2014; Siksou et al., 44 
2009; Weimer et al., 2006). At the molecular level, this morphological phenotype 45 
most likely corresponds to a role of Munc13s in mediating the formation of SNARE 46 
complexes at vesicular release sites (Hammarlund et al., 2007; Hammarlund et al., 47 
2008; Imig et al., 2014; Ma et al., 2011; Ma et al., 2013; Yang et al., 2015).  48 
The Munc13 family consists of five members, Munc13-1 (Unc13a), Munc13-2 49 
(Unc13b), Munc13-3 (Unc13c), the brain specific angiogenesis inhibitor I-associated 50 
protein 3 (Baiap3), and the non-neuronal isoform Munc13-4 (Unc13d) (Koch et al., 51 
2000). Genetic deletion of Unc13a and Unc13b completely eliminates SV exocytosis 52 
in hippocampal neurons (Varoqueaux et al., 2002), and selectively reduces synaptic 53 
vs. extrasynaptic exocytosis of neuronal LDCVs (van de Bospoort et al., 2012), which 54 
indicates that SV and LDCV exocytosis at active zones is mediated by similar 55 
molecular mechanisms. By contrast, studies in C. elegans and Drosophila have shown 56 
that Unc-13/dUnc-13 selectively regulate SV release, whereas the Ca2+-dependent 57 
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activator proteins for secretion (CAPS/Unc-31) specifically regulate LDCV release 58 
(Hammarlund et al., 2008; Renden et al., 2001; Speese et al., 2007; Zhou et al., 2007).  59 
In mammals, Munc13s and CAPSs appear to perform non-redundant functions critical 60 
for both SV and LDCV exocytosis in neurons (Jockusch et al., 2007; van de Bospoort 61 
et al., 2012), as well as for LDCV exocytosis in neuroendocrine cells (Elhamdani et 62 
al., 1999; Kabachinski et al., 2014; Kang et al., 2006; Kwan et al., 2006; Liu et al., 63 
2010; Liu et al., 2008; Speidel et al., 2008). Yet, to date, while CAPS-1 and CAPS-2 64 
have been shown to be required for LDCV exocytosis in mammalian chromaffin cells 65 
(Liu et al., 2010; Liu et al., 2008), evidence that endogenous Munc13s are required 66 
for LDCV exocytosis is lacking. In fact, the role of Munc13-1 and ubMunc13-2 has 67 
only been examined in the context of overexpression studies, and other isoforms have 68 
not been investigated (Ashery et al., 2000; Bauer et al., 2007; Liu et al., 2010; Stevens 69 
et al., 2005; Zikich et al., 2008). 70 
In the present study, we performed the first comprehensive analysis of all neuronal 71 
and neuroendocrine members of the Munc13 protein family in chromaffin cells, 72 
defining their respective roles in LDCV exocytosis. We identify the Ca2+-dependent 73 
step in the priming process at which Munc13-1 and ubMunc13-2 operate, and 74 
demonstrate that, although they are critical for LDCV priming and release, LDCV 75 




Expression of Munc13 isoforms in the mouse adrenal gland 79 
We first analyzed the expression of all Munc13 isoforms in the murine adrenal gland 80 
by Western blotting (Figure 1). In perinatal adrenal glands, we detected Munc13-1 81 
(Figure 1A and Figure 1–figure supplement 1B), the ubiquitous isoform ubMunc13-2 82 
(Figure 1B and Figure 1–figure supplement 1B), and Baiap3 (Figure 1D). Not 83 
detected were the brain-specific isoform of Munc13-2 (bMunc13-2), which is a splice 84 
variant expressed from the same gene as ubMunc13-2 (Figure 1B), Munc13-3 (Figure 85 
1C), and the non-neuronal isoform Munc13-4 (Figure 1E). To directly compare the 86 
expression levels of Munc13-1, ubMunc13-2, bMunc13-2, and Munc13-3, we used 87 
knockin mice that express these proteins fused to enhanced yellow or green 88 
fluorescent protein (EYFP/EGFP) from the respective endogenous loci (Cooper et al., 89 
2012; Kalla et al., 2006). We found that ubMunc13-2-EYFP is the only isoform 90 
readily detectable in the adrenal gland using an antibody to the GFP-derived tags 91 
(Figure 1–figure supplement 1A).  92 
To assess whether the isoforms detected in whole gland homogenates are present in 93 
the adrenal medulla, and/or the adrenal cortex, we dissected adult wild-type (WT) 94 
adrenal glands, and used an antibody to the LDCV marker Chromogranin A (CgA) to 95 
monitor effective separation of the medullary tissue, which consists mostly of 96 
chromaffin cells, from cortical tissue (Figure 1F). The expression of Munc13-1 and 97 
Baiap3 in the adrenal gland is largely restricted to the medulla. Expression of 98 
ubMunc13-2 was detected in both adrenal medulla and cortex. Thus, a significant 99 
fraction of the ubMunc13-2 signal detected in whole gland homogenates (Figure 1B) 100 
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appears to originate from the adrenal cortex, possibly due to innervation of the cortex 101 
by ubMunc13-2 positive synapses. 102 
 103 
Absence of Munc13-1, Munc13-3, or Baiap3 does not impair LDCV exocytosis in 104 
chromaffin cells 105 
Next, we analyzed cultured chromaffin cells from knockout (KO) mice deficient for 106 
the individual Munc13 isoforms (Figure 2). LDCV exocytosis was triggered using 107 
flash photolysis of caged Ca2+, which causes a sharp global increase in intracellular 108 
[Ca2+] (Neher, 2006). Fusion of LDCVs with the plasma membrane was monitored by 109 
measurement of the membrane capacitance change (ΔCm). Fitting a sum of three 110 
exponentials to the exocytotic burst of each individual trace identifies the amplitudes 111 
and time constants of release, which are generally interpreted as two kinetically 112 
distinct vesicle pools, the fast burst as the Readily-Releasable Pool (RRP), and the 113 
slow burst as the Slowly-Releasable Pool (SRP) (Sorensen et al., 2003a; Voets, 2000). 114 
However, as will be discussed later, the slow burst component may in fact not be a 115 
releasable pool, but instead represent the conversion from a Non-Releasable Pool 116 
(NRP), to the RRP (Walter et al., 2013). The rate of sustained release was measured 117 
as a linear component after the exocytotic burst, and reflects the ongoing recruitment 118 
of LDCVs into the NRP/SRP and RRP. Deletion of Munc13-1 (Unc13a), the major 119 
Munc13 isoform in SV exocytosis (Augustin et al., 1999; Varoqueaux et al., 2002), 120 
did not markedly alter LDCV exocytosis compared to WT littermate controls (Figure 121 
2A,D), nor did it affect the kinetics of the exocytotic burst (Figure 2D).  122 
Although we did not detect Munc13-3 in the adrenal gland, we wanted to rule out 123 
possible physiological effects of protein expression below the detection limit of 124 
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Western blot analysis (Figure 1C), and included Unc13cKO mice in our analysis. 125 
However, as expected, LDCV exocytosis in Unc13cKO chromaffin cells was not 126 
perturbed (Figure 2B,D).  127 
We then investigated the possible role of Baiap3 in LDCV exocytosis, as this isoform 128 
is prominently expressed in the adrenal medulla (Figure 1D,F). Surprisingly, LDCV 129 
exocytosis in Baiap3KO cells was intact (Figure 2C,D). Furthermore, Baiap3KO cells 130 
also did not show a release deficit when we stimulated the cells using a series of 131 
depolarization steps (Figure 2–figure supplement, 1A-C), nor did overexpression of 132 
Baiap3 in WT cells affect LDCV exocytosis (Figure 2–figure supplement 1D-F). 133 
 134 
Absence of ubMunc13-2 dramatically reduces LDCV release  135 
We then analyzed the role of ubMunc13-2 and Munc13-1 in chromaffin cell LDCV 136 
exocytosis. For this purpose, we used an Unc13a/b  (DKO) mouse line. Heterozygous 137 
(Het) animals of this line express ~50 % of WT levels of Munc13-1 and Munc13-2, 138 
which does not affect neurotransmission (Augustin et al., 1999; Varoqueaux et al., 139 
2002). Data were collected from genotype groups available for a given litter and were 140 
pooled for analysis. Because our breeding scheme did not produce littermate WT 141 
animals in sufficient numbers, and because deletion of Unc13a alone was without 142 
effect, data from Unc13aWTUnc13bHet and Unc13aHetUnc13bHet cells were pooled and 143 
used as control (Figure 2E-J, Unc13aWT/HetUnc13bHet). 144 
Deletion of both Unc13a alleles together with a single Unc13b allele 145 
(Unc13aKOUnc13bHet) did not reduce LDCV release (Figure 2E,F). By contrast, 146 
abrogation of ubMunc13-2 expression alone, irrespective of the Unc13a genotype, 147 
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drastically diminished release (Figure 2E,F). Furthermore, in the context of the 148 
Unc13bKO background, cells with Unc13aWT, Unc13aHet, and Unc13aKO genotypes 149 
showed a progressive reduction of LDCV release that depended on the number of 150 
Unc13a alleles present (Figure 2F,G). The fast and slow burst components were 151 
reduced to 39%, 32%, and 27%, and to 54%, 52%, and 42% of control levels, 152 
respectively (Figure 2F). The rate of sustained release was reduced even more 153 
dramatically, to 26%, 19%, and 12% of control levels (Figure 2F). When one uses the 154 
Unc13aWTUnc13bKO genotype as a reference point (Figure 2G), the deletion of 155 
Unc13a caused a reduction of the sustained release component to 48%. The rate of 156 
sustained release of Unc13aKOUnc13bKO cells was also significantly reduced when 157 
compared to Unc13aHetUnc13bKO cells.  158 
The deletion of both Unc13a and Unc13b significantly delayed the onset of vesicular 159 
exocytosis triggered by flash photolysis, compared to control and 160 
Unc13aKOUnc13bHet cells (Figure 2H). Unc13aWTUnc13bKO cells also showed a mild 161 
increase in delay. However, this difference was significant only when compared to 162 
Unc13aKOUnc13bHet cells, but not compared to the other groups. 163 
Thus, ubMunc13-2, the only isoform expressed from the Unc13b gene in mouse 164 
chromaffin cells, is the most critical isoform for LDCV release in this cell type. 165 
Moreover, in its absence it becomes apparent that endogenous Munc13-1 also 166 





Reduced IRP and RRP in the absence of ubMunc13-2 171 
We next assessed whether ubMunc13-2 affects LDCV release in response to Ca2+ 172 
entry through voltage-gated Ca2+ channels by stimulating the cells with a series of 173 
depolarization steps (Figure 3). The first six short depolarizations of the train release 174 
the Immediately-Releasable Pool (IRP), i.e. the subset of RRP vesicles located closest 175 
to Ca2+-channels (Schonn et al., 2010; Voets et al., 1999). We found a significant 176 
reduction in LDCV release; the size of the RRP in Unc13bKO cells was reduced to 177 
53% of WT levels (Figure 3C). This deficit is somewhat less pronounced than the 178 
reduction seen in the flash photolysis experiment (reduction to 39%, Figure 2F), most 179 
likely because the depolarization protocol used to obtain the data shown in Figure 3 180 
lasts several seconds and therefore causes some ongoing recovery of the RRP. By 181 
contrast, in flash photolysis experiments, the RRP is probed within ∼60 ms (3 times 182 
the time constant), which is much faster than the recovery of the RRP. Strikingly, in 183 
the depolarization experiment, impaired release in Unc13bKO cells was already 184 
evident in response to the first 10-ms depolarization (Figure 3B), which implies that 185 
lack of ubMunc13-2 would even affect resting level catecholamine release driven by 186 
low frequency stimulation (Zhou and Misler, 1995).  187 
 188 
Reduced catecholamine release in the absence of ubMunc13-2 189 
To understand how ubMunc13-2 affects the kinetics of single catecholamine release 190 
events, we performed single spike amperometry while infusing the cells with a 191 
solution with moderate (∼4.6 µM) [Ca2+] (Figure 4). Unc13bKO cells showed a 192 
dramatic reduction in spike frequency (Figure 4B,C), whereas basic spike parameters 193 
such as duration, half-width, maximum amplitude, charge, rise time, and decay time 194 
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were unchanged (Figure 4D-I). Amplitude, duration and charge of the spike foot 195 
signal, which is thought to reflect release during the initial formation of the fusion 196 
pore prior to full fusion, were also unchanged (Figure 4J-L). However, we found that 197 
the number of spikes that did show these foot signals was slightly reduced in 198 
Unc13bKO cells (Figure 4M), which may indicate that fusion pore dynamics are 199 
altered for some release events. However, overall, the LDCVs undergoing fusion in 200 
the absence of ubMunc13-2 do so without major alterations in fusion kinetics or 201 
vesicle content.  202 
 203 
Munc13 isoforms display different LDCV priming efficiencies 204 
As our experiments so far showed that, with the exception of Baiap3, the contribution 205 
of the Munc13 isoforms to the regulation of LDCV release correlates with their level 206 
of expression in perinatal adrenal glands, we next wanted to compare the intrinsic 207 
properties of the different isoforms. To this end, we overexpressed Munc13-1, 208 
ubMunc13-2, Baiap3, and its closest relative Munc13-4 using Semliki Forest Virus 209 
(SFV) in Unc13aKOUnc13bKO cells. Munc13-1 and ubMunc13-2 were expressed as 210 
EGFP fusion constructs whose functions are identical to those of the respective WT 211 
proteins (Rosenmund et al., 2002), whereas Baiap3 and Munc13-4 were expressed as 212 
internal ribosome entry site (IRES)-EGFP constructs, to avoid possible confounding 213 
effects of a fusion tag. Unc13aKOUnc13bKO cells expressing only EGFP were used as 214 
control. For the purpose of comparison, the averaged traces obtained from the rescue 215 
experiments with the four isoforms were plotted in the same graph (Figure 5A). The 216 
exocytotic burst was measured as the ΔCm within the first 0.5 s after the flash 217 
stimulus, and the rate of sustained release was measured as the ΔCm between 0.5 s 218 
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and 4 s after the flash (Figure 5B). Interestingly, Munc13-1 and ubMunc13-2 were 219 
both able to rescue the LDCV release deficit of Unc13aKOUnc13bKO cells (Figure 220 
5A,B). However, rescue with ubMunc13-2 resulted in an enormous enhancement of 221 
LDCV exocytosis to levels that by far exceeded the amount of exocytosis typical of 222 
WT cells, for both the exocytotic burst and the rate of sustained release (Figure 223 
5A,B). The direct comparison of Munc13-1 and ubMunc13-2 expressing cells with 224 
matching EGFP fluorescence intensity confirmed that the stronger enhancement of 225 
burst size and rate of sustained release in ubMunc13-2 expressing cells was not due to 226 
higher expression levels of ubMunc13-2 (Figure 5–figure supplement 1). 227 
Overexpression of Baiap3 failed to rescue the LDCV release deficit of the 228 
Unc13aKOUnc13bKO chromaffin cells (Figure 5A,B). Yet, its closest relative, 229 
Munc13-4, which regulates SNARE-mediated vesicular exocytosis in the 230 
hematopoietic system (Feldmann et al., 2003; Shirakawa et al., 2004), was able to 231 
rescue LDCV exocytosis in Unc13aKOUnc13bKO cells, albeit less efficiently than 232 
Munc13-1 or ubMunc13-2 (Figure 5A,B). To exclude the possibility that these 233 
findings might be due to inefficient translation of Baiap3 and Munc13-4, protein 234 
expression was confirmed with isoform-specific antibodies in SFV-infected neuronal 235 
cultures, which provide enough material for Western blot analysis (Figure 5–figure 236 
supplement 2). Thus, individual Munc13 isoforms appear to show inherent 237 
differences in their ability to promote LDCV release in chromaffin cells.  238 
 239 
LDCV docking in the absence of ubMunc13-2 and Munc13-1 240 
We went on to investigate whether Unc13aKOUnc13bKO chromaffin cells show an 241 
LDCV docking defect analogous to the SV docking defect seen in 242 
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Unc13aKOUnc13bKO synapses (Siksou et al., 2009). SV docking deficits of 243 
Munc13/Unc-13 deficient synapses in mice and C. elegans were previously only 244 
detected when rapid cryo-fixation methods were employed instead of classical 245 
chemical fixation for ultrastructural analysis (Siksou et al., 2009; Weimer et al., 246 
2006). Moreover, it has been shown that 3D electron tomography (ET) allows a more 247 
accurate assessment of SV docking at the active zone (Imig et al., 2014; Siksou et al., 248 
2009). To study LDCV recruitment and docking in chromaffin cells, we therefore 249 
combined high-pressure freezing (HPF) and freeze-substitution of acute adrenal gland 250 
slices with classical 2D-EM (Figure 6A-E) and high-resolution 3D-ET analyses 251 
(Figure 6F-N). Quantitative analysis of 2D-EM images of Unc13aHetUnc13bHet 252 
(Figure 6A) and Unc13aKOUnc13bKO chromaffin cells (Figure 6B) did not reveal any 253 
differences in LDCV distribution within 2 μm of the plasma membrane (PM) (Figure 254 
6C), in the number of membrane-proximal LDCVs within 40 nm of the PM (Figure 255 
6D), or in the total number of LDCVs (Figure 6E). LDCV docking and recruitment 256 
into the vicinity of the PM were assessed using 3D-ET (Figure 6F-N). From all 257 
LDCVs analyzed within 100 nm of the PM, the percentage of membrane-proximal 258 
LDCVs (0-40 nm) (Figure 6M) and their distribution (Figure 6L) was unaltered 259 
between both groups, indicating that LDCV recruitment to the PM is intact in 260 
Munc13-deficient chromaffin cells. The number of docked LDCVs, defined as 261 
LDCVs in physical contact with the PM and assigned to the 0-4 nm bin in Figure 6L, 262 
and the number of docked LDCVs normalized to the number of membrane-proximal 263 
LDCVs (Figure 6N) were unchanged. Furthermore, the average LDCV diameter of 264 
docked or non-docked LDCVs, measured by 3D-ET, did not differ significantly 265 
between genotypes, although Unc13aKOUnc13bKO LDCVs tended to be smaller 266 
(Figure 6–figure supplement 1). Thus, in spite of the dramatic release deficit seen in 267 
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Unc13aKOUnc13bKO chromaffin cells and the dramatic SV docking deficit seen in 268 
neurons of this genotype (Siksou et al., 2009), we did not detect any changes in 269 
LDCV docking, nor a loss or accumulation of LDCVs in the vicinity of the PM. Thus, 270 
chromaffin cells can generate what appears to be a full-sized pool of morphologically 271 
docked LDCVs in the absence of Munc13-1 and Munc13-2, which implies that the 272 
molecular requirements of morphological LDCV and SV docking are distinct. 273 
Additionally, this could either indicate that the mechanism of functional docking, i.e. 274 
priming, differs between LDCV and SVs as well, or else, that the primed LDCVs (i.e. 275 
those that belong to the RRP) are in the minority among the docked vesicles and 276 
therefore cannot be detected. 277 
To distinguish between these two possibilities, we estimated the total number of 278 
docked LDCVs per cell. To this end, we re-calculated the percentage of docked 279 
vesicles identified using 3D-ET, as the percentage of membrane proximal vesicles (0-280 
40 nm) identified in the 2D-EM analysis and converted LDCVs/μm PM to 281 
LDCVs/cell as described (Parsons et al., 1995). This conversion was necessary due to 282 
the limited volume sizes analyzed by 3D-ET and the uneven distribution of LDCVs 283 
within the cells. The estimated size of the morphologically docked pool was ∼662 284 
LDCVs per chromaffin cell in control cells. For Unc13aKOUnc13bKO cells we 285 
calculated ∼865 docked LDCVs per cell, which can be accounted for by two factors 286 
used in the calculation: Unc13aKOUnc13bKO cells are slightly larger, and their LDCVs 287 
are slightly smaller (Figure 6–figure supplement 1). Both values are lower than the 288 
previously reported ∼1607 for embryonic day (E)18 murine chromaffin cells (de Wit, 289 
2010), presumably reflecting improved discrimination between docked and undocked 290 
vesicles by 3D-ET. With a diameter of a docked LDCV of ∼170 nm (Figure 6–figure 291 
supplement 1E) and assuming a specific membrane capacitance of 1 μF/cm2, this 292 
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corresponds to a vesicular capacitance of 0.91 fF, in excellent agreement with recent 293 
electrophysiological measurements of 0.94 fF (Pinheiro et al., 2014). Thereby, the 294 
size of the RRP, which is <40 fF at resting [Ca2+] (Voets, 2000), corresponds to <44 295 
vesicles from the total of ∼662 in control cells, indicating that even with 3D-ET, the 296 
RRP will be very hard or even impossible to distinguish morphologically from other 297 
docked vesicles in adrenal chromaffin cells.  298 
 299 
Identification of a Munc13-sensitive step in LDCV priming 300 
Thus far, our data indicate that although morphological docking of LDCVs does not 301 
require Munc13s, the priming of a functional RRP does. We therefore wanted to 302 
identify the Munc13-sensitive step in the LDCV priming process, and compare the 303 
intrinsic properties of Munc13-1 and ubMunc13-2, the two most relevant isoforms in 304 
the adrenal medulla. In a recently published mathematical model for LDCV fusion, 305 
we showed that the fast and slow bursts of release originate from two serially 306 
arranged pools of vesicles, the RRP and the non-releasable NRP, respectively (Walter 307 
et al., 2013) (Figure 7). The NRP in turn is refilled from a larger depot pool. Thus, the 308 
model features two separate priming steps (Liu et al., 2010), but only one fusion 309 
pathway (Figure 7E). Since the deletion of Unc13a and Unc13b changed the fast and 310 
slow burst to nearly the same degree (Figure 2F), within the framework of this model, 311 
Munc13s must act upstream of the NRP. Furthermore, since the sustained release rate 312 
is changed proportionally as well, Munc13s likely act to accelerate the forward 313 
priming rate, k1 (Ashery et al., 2000). In most models, this rate constant k1 is Ca2+-314 
dependent (Voets, 2000; Walter et al., 2013), and confers overall Ca2+-dependence to 315 
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the primed vesicle pool. We next investigated how the two relevant Munc13-isoforms 316 
in chromaffin cells (ubMunc13-2, Munc13-1) affect this priming step. 317 
The Ca2+-dependence of LDCV-priming (essentially k1 in Figure 7E) can be assessed 318 
in an experiment by varying the pre-flash intracellular [Ca2+], before an uncaging 319 
flash is used to probe the size of the primed vesicle pool (Voets, 2000). We expressed 320 
either Munc13-1 or ubMunc13-2 in Unc13aKOUnc13bKO cells and extended the range 321 
of pre-flash [Ca2+] values from the previously used 300-600 nM (Figure 2 and Figure 322 
5) to 250-1200 nM (Figure 7A and Figure 7–figure supplement 1). In order to 323 
compare the respective Ca2+-sensitivities rather than the absolute priming rates of 324 
Munc13-1 and ubMunc13-2 – and to overcome cell-to-cell variability – we 325 
normalized capacitance traces to their value after 3 s (Figure 7A, left and middle 326 
panels). Using the fractional increase in capacitance after 30 ms as a read-out of the 327 
primed vesicle pool, we identified the characteristic Ca2+-dependence of priming. 328 
Strikingly, the Ca2+-dependence was almost identical for the two isoforms and could 329 
be fitted with a single Hill equation (Figure 7A right-hand panel, Table 1).  330 
Thus, Ca2+-dependent priming is supported with identical steady-state affinities in the 331 
presence of Munc13-1 or ubMunc13-2. However, when applying Ca2+-uncaging 332 
flashes from a relatively low pre-flash [Ca2+], the two isoforms induce quite different 333 
secretion kinetics (Figure 7B,C). For ubMunc13-2, secretion shows a clear sigmoid 334 
shape with acceleration after ∼0.5 s (Figure 7C), which is absent when the pre-flash 335 
[Ca2+] is higher. This sigmoid shape of ubMunc13-2 driven secretion was noted 336 
before and was attributed to a slow association of ubMunc13-2 with Calmodulin and 337 
Ca2+, resulting in a slow “priming switch” (Zikich et al., 2008). In contrast, Munc13-1 338 
does not show this secondary acceleration (Figure 7B), regardless of the pre-flash 339 
[Ca2+]. To understand the origin of this behavior, we modeled the Ca2+ association 340 
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with the priming sensor (PS) explicitly - in our previous model (Walter et al., 2013), 341 
this step had been assumed to be always in equilibrium. In accordance with the 342 
observed identical steady state Ca2+ dependencies (Figure 7A), we used identical 343 
dissociation constant (KD) values for both isoforms, and varied only the on-rate, kon, 344 
(the off-rate was changed simultaneously, koff = KD*kon, with constant KD). This led 345 
to a very satisfactory fit to both Munc13-1 and ubMunc13-2 data from both low and 346 
high pre-flash [Ca2+] (Figure 7B,C). Also, this model made it possible to fit both the 347 
control trace, and the Unc13bKO trace (Figure 7D). Importantly, the fit was performed 348 
simultaneously to all traces, so that we could ensure consistency between fits, 349 
simplify the interpretation of parameter changes, and ensure that all conditions could 350 
be reproduced by one version of our model (for fitted parameters, refer to Table 1). 351 
Our model (Figure 7E) assumes that the NRP vesicles can only fuse after maturing to 352 
the RRP state (Walter et al., 2013). Earlier models assumed that the 'NRP pool' can 353 
fuse directly via an alternative pathway; in those cases, the corresponding pool was 354 
called ‘Slowly Releasable’ (SRP) (Voets, 2000). We note that our conclusion that 355 
Munc13-1/ubMunc13-2 exert their main effects upstream of both pools (NRP/SRP 356 
and RRP), i.e. on k1, is consistent with both ideas (see also Ashery et al., 2000).  357 
Therefore our observations here do not necessarily distinguish between the parallel 358 
pool model (SRP and RRP are both releasable) and the sequential pool model (only 359 
the RRP is releasable); but see (Walter et al., 2013) for data supporting the sequential 360 
pool model). 361 
The modeling resulted in two main conclusions (Table 1): First, as expected, the 362 
action of Munc13 (either isoform) is consistent with an increase in k1 – the forward 363 
rate of priming within the first priming step (Figure 7E). This is seen both by the 364 
increase in the fitted k1 upon overexpression of either isoform, and by the decrease of 365 
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k1 in the Unc13bKO cells. Second, ubMunc13-2 increases k1 4.5-fold more than 366 
Munc13-1, but it does so after a longer delay. In the model, this delay is due to slower 367 
kinetics of Ca2+ binding to the priming sensor (Zikich et al., 2008). Note that this step 368 
might coincide with the translocation of Munc13-1 or ubMunc13-2 to the membrane 369 
as a prerequisite for the priming action of the protein. Thus, the different delays might 370 
reflect differences in the membrane translocation step. As a minor note, we also 371 
noticed that k2, the forward rate of downstream priming (“priming 2”, Figure 7E) 372 
always changed in the opposite direction of k1. The reason for this is unclear, but one 373 
explanation could be that the protein(s) driving downstream priming compete with 374 
Munc13 for association with the fusion machinery.  375 
 376 
  377 
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Discussion 378 
Our study provides a comprehensive analysis of the Munc13 protein family in LDCV 379 
docking and priming, and shows that genetic deletion of Munc13-1 (Unc13a) and 380 
Munc13-2 (Unc13b) severely impairs LDCV release in chromaffin cells. Yet 381 
surprisingly, LDCV docking, unlike SV docking, does not require Munc13s. We 382 
furthermore identify the step most sensitive to Munc13s in the LDCV priming 383 
process, and show that ubMunc13-2 and Munc13-1 accelerate this step with identical 384 
Ca2+ affinities but distinct Ca2+ binding rates. 385 
The essential role of Munc13s in vesicular release appears to lie in the opening of 386 
Syntaxin (Stx-1)/Munc18-1 complexes, to permit the formation of Stx-1/SNAP-25 387 
heterodimers that act as docking platforms for the vesicular SNARE protein 388 
Synaptobrevin-2 (Syb-2) (Hammarlund et al., 2007; Ma et al., 2011; Ma et al., 2013; 389 
Richmond et al., 1999; Sassa et al., 1999; Yang et al., 2015). SNARE complex 390 
assembly is thought to proceed in an N- to C-terminal zipper-like fashion (Fasshauer 391 
and Margittai, 2004; Pobbati et al., 2006; Sorensen et al., 2006; Walter et al., 2010), 392 
and, at least for SVs, this assembly seems to be the molecular correlate of both the 393 
physical docking process, and acquisition of fusion competence, which is referred to 394 
as priming (Imig et al., 2014). However, as will be discussed below, morphological 395 
docking of LDCVs does not require Munc13s (Figure 6), yet the priming of a full-396 
sized RRP does (Figure 2), indicating that LDCV docking and functional priming do 397 




LDCV and SV docking have distinct requirements 401 
Our data demonstrate that although Munc13s are critical for functional priming of 402 
LDCVs in chromaffin cells, morphological LDCV docking, even when assessed by 403 
3D-ET at unprecedented resolution, is not impaired in the absence of Munc13s 404 
(Figure 6). Thus, in contrast to synapses, where most, if not all docked SVs are part of 405 
the RRP, the majority of docked LDCVs in chromaffin cells are not primed, and the 406 
functional RRP therefore cannot be distinguished from other docked LDCVs by 407 
current ultrastructural methods. Although we cannot completely exclude the 408 
possibility that Munc13-3 and Munc13-4 may be present at very low levels, that we 409 
were unable to detect (Figure 1), it seems unlikely that their presence could account 410 
for the full-sized pool of docked LDCVs in Unc13aKOUnc13bKO cells.  411 
This raises the question of how the non-primed LDCVs are docked. SV docking 412 
requires the SNARE proteins Stx-1, SNAP-25, and Syb-2, as well as Munc13s and 413 
CAPSs, but not necessarily the Ca2+ sensor of fusion, Synaptotagmin-1 (Syt-1) (Imig 414 
et al., 2014). By contrast, current models imply that LDCV docking is mediated by 415 
Syt-1, possibly via interaction with the Stx-1/SNAP-25 acceptor complex (de Wit et 416 
al., 2006; de Wit et al., 2009; Parisotto et al., 2012). Additionally, Munc18-1 docks 417 
LDCVs via its interaction with the closed form of Stx-1 (Gandasi and Barg, 2014; 418 
Gerber et al., 2008; Gulyas-Kovacs et al., 2007; Han et al., 2011; Voets et al., 2001) 419 
and is also involved in an additional tethering step (Toonen et al., 2006). The 420 
vesicular SNAREs seem to be dispensable for docking in chromaffin cells 421 
(Borisovska et al., 2005; Gerber et al., 2008), although they have been implicated in 422 
PC12 cells (Wu et al., 2012). Some of these discrepancies are most likely due to 423 
methodological and terminological differences as well as to limitations in assessing 424 
true membrane attachment. However, since we used the same experimental approach 425 
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previously employed to detect SV docking deficits (Imig et al., 2014; Siksou et al., 426 
2009), our data clearly show that the molecular requirements of SV and LDCV 427 
docking are distinct. More specifically, while the formation of the docked/primed 428 
RRP requires Munc13s in both cases, and thus appears to be mechanistically quite 429 
similar for SVs and LDCVs, the non-primed LDCVs in chromaffin cells appear to 430 
dock via a separate, Munc13-independent mechanism. 431 
 432 
Our findings are therefore consistent with the following model of LDCV docking and 433 
priming: (i) LDCV docking mediated by Munc18-1/Stx-1, this configuration would 434 
be the starting point for Munc13-mediated SNARE complex assembly, i.e. priming 435 
(Ma et al., 2011; Ma et al., 2013), and in parallel, (ii) LDCV docking mediated by a 436 
second configuration, that would not be expected to progress to SNARE complex 437 
assembly directly or as efficiently, and thus be consistent with the large unprimed, but 438 
docked LDCV pool. What this second configuration would look like in terms of 439 
molecular interactions is less clear. Docking via Syt-1/Stx-1/SNAP-25 complexes 440 
would be consistent with un-primed docking (de Wit et al., 2009). This mode of 441 
docking would require the assumption that in chromaffin cells, Stx-1/SNAP-25 442 
complexes can escape NSF/SNAP mediated disassembly. An additional or alternative 443 
mode of un-primed docking may involve the recruitment of vesicles based on the 444 
interaction of Syt-1 with phosphatidylinositol 4,5-bisphosphate (PIP2)/Stx-1 clusters 445 
(Honigmann et al., 2013; Park et al., 2015), although further interactions may be 446 
required to achieve close membrane apposition. 447 
In the model suggested above, we explicitly included only molecular components for 448 
which docking deficits have been demonstrated in chromaffin cells. However, LDCV 449 
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docking most likely involves additional factors. For instance, the docking of LDCVs 450 
to Munc18-1/Stx-1 complexes probably requires the interaction between Munc18 and 451 
the vesicle-associated small GTPases Rab3 and Rab27 (Graham et al., 2008; Tsuboi 452 
and Fukuda, 2006; van Weering et al., 2007), and additional docking/tethering factors 453 
may be involved in docking both primed and un-primed LDCVs to the membrane.  454 
 455 
Release kinetics of LDCV pools as correlates of SNARE complex assembly 456 
Our analysis of how Munc13s prime LDCVs for fusion identifies the earliest phase of 457 
the priming process as the step most sensitive to Munc13s. We interpret our data 458 
according to a model that features Munc13 as a Ca2+-sensitive priming protein in a 459 
single pathway to LDCV fusion with two serially arranged vesicle states or pools 460 
(NRP and RRP) (Figure 7E). This essentially allows us to describe what was 461 
previously interpreted as the release of two kinetically distinct LDCV pools (SRP and 462 
RRP), as two sequential priming processes, priming 1 and priming 2, resulting in only 463 
one releasable pool, the RRP (Walter et al., 2013). According to previous data, the 464 
step most sensitive to Munc13s – priming 1 – is also the step affected by mutations 465 
designed to interfere with the initiation of N-terminal SNARE complex assembly 466 
(Walter et al., 2013; Walter et al., 2010). This is in line with a function of Munc13s in 467 
initiating SNARE-complex assembly (Yang et al., 2015). The second priming step 468 
may involve a downstream, presumably more C-terminal phase of SNARE-complex 469 
assembly, although other options remain open. Thus, in the model (Figure 7E), the 470 
formation of the NRP, i.e. the step most sensitive to Munc13s, most likely represents 471 
the initiation of N-terminal SNARE complex assembly.  472 
 473 
 22
Catalysis of fast and slow LDCV priming by Munc13-1 and ubMunc13-2 474 
As our study demonstrates, Munc13 isoforms differ in their ability to facilitate LDCV 475 
priming (Figure 5). We detected three endogenously expressed isoforms in murine 476 
chromaffin cells, Munc13-1, ubMunc13-2, and Baiap3 (Figure 1). Baiap3, somewhat 477 
surprisingly given its prominent expression and ability to translocate to membranes in 478 
a Ca2+-dependent manner (Lecat et al., 2015), does not appear to be involved in 479 
LDCV priming in this cell type. However, Munc13-4, which regulates SNARE- 480 
mediated vesicle exocytosis in the hematopoietic system (Boswell et al., 2012; 481 
Feldmann et al., 2003; Shirakawa et al., 2004), and is the closest relative of Baiap3 482 
(Koch et al., 2000), can promote LDCV priming, albeit less efficiently than Munc13-483 
1 and ubMunc13-2. 484 
The two most relevant isoforms, Munc13-1 and ubMunc13-2, promote LDCV 485 
priming with very similar steady-state Ca2+-affinities, but nonetheless confer unique 486 
release kinetics depending on the pre-stimulus [Ca2+]. Modeling of the secretion 487 
kinetics produced by overexpression of Munc13-1 and ubMunc13-2 in 488 
Unc13aKOUnc13bKO cells allowed us to isolate the intrinsic properties of each isoform 489 
(Table 1). Secretion driven solely by the dominant isoform ubMunc13-2 shows a 490 
characteristic sigmoid shape at low pre-stimulus [Ca2+] (Figure 7C) (Zikich et al., 491 
2008). In our secretion model, the best-fit parameters indicate 2.5-fold slower sensing 492 
of [Ca2+] for ubMunc13-2, which can however accelerate priming dramatically when 493 
[Ca2+] increases. Thus, the fitted maximum priming rate (k1) for ubMunc13-2 is 4.5-494 
fold higher than for Munc13-1. However, although Munc13-1 is unable to support the 495 
same maximum priming rate as ubMunc13-2, it reacts faster to a change in the [Ca2+] 496 
concentration (Figure 7B), which may reflect distinct conformational changes in 497 
response to [Ca2+], and/or differences in a membrane translocation step. 498 
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 499 
Thus, neuroendocrine cells can fundamentally modify the kinetics of secretion by 500 
expressing different Munc13 isoforms. Previous data from autaptic neurons showed 501 
that Munc13-1 causes short term depression, whereas ubMunc13-2 causes short-term 502 
facilitation (Rosenmund et al., 2002), which parallels our findings in chromaffin cells 503 
from low basal [Ca2+], raising the possibility that the functions of different Munc13 504 
isoforms in priming LDCVs and SVs are conserved, even though their role in docking 505 
is not. Our model therefore provides a theoretical framework for how the molecular 506 
properties of priming factors may be linked to the kinetics of exocytosis. 507 
 508 
Sequential actions of upstream and downstream priming catalysts 509 
Although Munc13s have the strongest effect on the priming step 1, i.e. the formation 510 
of the NRP vesicle state, they also influence priming step 2, i.e. the formation of the 511 
RRP. Remarkably, overexpression and deletion of Munc13s change the rate constants 512 
k1 (priming 1) and k2 (priming 2) in opposite directions (Figure 7D). One possible 513 
reason for this effect could be that the interaction of Munc13s with the SNARE fusion 514 
machinery may compete with that of another priming protein, which mainly catalyzes 515 
priming step 2. A likely candidate for this second catalyst appears to be CAPS, as 516 
deletion of CAPS1 and CAPS2 leads to a significant reduction of the RRP, but has 517 
little effect on the NRP/SRP, placing Munc13 upstream of CAPS (Liu et al., 2010; 518 
Liu et al., 2008).  519 
Furthermore, in PC12 cells, strong stimulation bypasses the need for CAPS-1 in 520 
LDCV exocytosis, but not the need for ubMunc13-2 (Kabachinski et al., 2014), and 521 
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the ability of CAPS to promote membrane fusion is impaired by C-terminal mutations 522 
in Stx-1 (Daily et al., 2010). We therefore propose an LDCV priming model, in which 523 
the Munc13-driven priming step 1 corresponds to the initiation of N-terminal 524 
SNARE-complex assembly, and the CAPS-driven priming step 2 represents a more 525 
C-terminal, and presumably more easily completed phase of zippering (Gao et al., 526 
2012). Assuming that priming step 2 is not catalyzed by CAPS alone but also 527 
influenced by Munc13 and possibly Syt-1, such a model would also offer an 528 
explanation as to why in both SV and LDCV exocytosis, lack of CAPS can be 529 
compensated for by an increase in Ca2+, whereas lack of Munc13 cannot (Jockusch et 530 
al., 2007; Kabachinski et al., 2014). 531 
 532 
Conclusion 533 
In summary, our data show that mammalian neurons and neuroendocrine cells both 534 
require Munc13s to generate fusion-competent vesicles, although the molecular steps 535 
leading to LDCV docking prior to SNARE complex assembly appear to be unique. In 536 
LDCV priming, the step most sensitive to Munc13s is the initial phase (priming step 537 
1), which most likely corresponds to the initiation of N-terminal SNARE-complex 538 
assembly. Individual Munc13 isoforms accelerate this step at distinct rates, thereby 539 
imparting distinct properties on the kinetics of LDCV release, which indicates that 540 
they may have specialized functions in the fine-tuning of catecholamine release in 541 
response to varying physiological stimuli. 542 
  543 
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Materials and methods 544 
Animals  545 
All experiments were performed in compliance with the regulations of the local 546 
Animal Care and Use Committee of Lower Saxony, Oldenburg, Germany. The 547 
generation and basic characterization of the KO lines of the Munc13 isoforms has 548 
been described previously (Augustin et al., 2001; Augustin et al., 1999; Varoqueaux 549 
et al., 2002; Wojcik et al., 2013). Unc13dKO (Unc13dJinx) mice (Crozat et al., 2007) 550 
were obtained from Jackson Laboratories. Adult and perinatal mice were killed by 551 
decapitation prior to the removal of adrenal glands and other tissues. 552 
 553 
Western blotting and antibodies 554 
Adrenal glands of perinatal animals were excised and stored at -80°C prior to use. 555 
Adrenal glands from around 20 perinatal animals were pooled for the preparation of 556 
homogenates. Homogenates of whole adrenal glands were prepared by 557 
homogenization in an ice-cold buffer (320 mM D-glucose, 20 mM HEPES, 2 mM 558 
EDTA, pH 7.4, with 0.5 μg/ml leupeptin, 1 μg/ml aprotinin and 0.1 mM PMSF added 559 
freshly prior to homogenization), using a Potter S homogenizer. For the preparation of 560 
adrenal cortical and medullary homogenates, adrenal glands from WT animals were 561 
dissected in ice-cold buffer containing 19 mM NaH2PO4 and 81 mM Na2HPO4 and 562 
material from 5-6 animals was pooled. Spleen homogenates were prepared similarly 563 
and the DNA in the samples subsequently digested with 0.66 U/μl benzonase (E1014, 564 
Sigma-Aldrich) in 3.86 mM MgCl2 for 10 min at 37°C prior to denaturation. Whole 565 
brain homogenates were prepared using a Potter S homogenizer and centrifuged for 566 
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10 min at 1000 g at 4°C to remove the nuclear fraction. Homogenates were analyzed 567 
by Western blotting with the following antibodies at the indicated dilutions: rabbit-568 
anti-Munc13-1 (1:500) (126103, Synaptic Systems), rabbit-anti-ubMunc13-2 569 
(1:2000), rabbit-anti-bMunc13-2 (1:1000), rabbit-anti-Munc13-3 (1:500) 570 
(Varoqueaux et al., 2005), rabbit-anti-Baiap3 (1:1000) (Wojcik et al., 2013), goat-571 
anti-Munc13-4 (1:250) (NB100-41385; Novus Biologicals), rabbit-anti-572 
Chromogranin A (1:8000) (259002; Synaptic Systems), mouse-anti-GFP (1:500) 573 
(11814460001; Roche), mouse-anti-valosin containing protein (VCP) (1:1000) 574 
(612182; BD Transduction Laboratories), and mouse-anti-GAPDH (1:25000) 575 
(ab8245; Abcam). Secondary antibodies (goat anti-rabbit IgG, 111035144; goat anti-576 
mouse IgG, 115035146, donkey anti-goat, 705-035-147) were obtained from Jackson 577 
ImmunoResearch. 578 
 579 
Chromaffin cell culture 580 
Chromaffin cell cultures were prepared as described in Sørensen et al. (Sorensen et 581 
al., 2003b). Cultures from Unc13aKO and Unc13aKOUnc13bKO mice were prepared on 582 
embryonic day (E)18, and from Unc13bKO, Unc13cKO, and Baiap3KO mice on 583 
postnatal day (P)0, in each case using littermates of the appropriate genotypes as 584 
controls. For overexpression of Baiap3 in WT cells, chromaffin cells from P0 WT 585 
C57Bl/6N mice were used. Briefly, adrenal glands were excised and placed into ice-586 
cold Locke’s solution (154 mM NaCl, 5.6 mM KCl, 0.84 mM NaH2PO4, 2.14 mM 587 
Na2HPO4 and 10 mM D-glucose, pH 7.0). The glands were then transferred to 300 μl 588 
of a papain solution [20 U/ml papain (Worthington Biochemical), 200 mg/L L-589 
cysteine, 1 mM CaCl2, 0.5 mM EDTA, in DMEM (Gibco)], which had been 590 
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equilibrated for 15 min with 95 % O2 and 5 % CO2, and incubated with gentle shaking 591 
for 45 min at 37°C. To terminate the papain digestion, 300 μl of inactivating solution 592 
[10 % fetal bovine serum (Gibco), 2.5 g/L trypsin inhibitor (Gibco) and 2.5 g/L 593 
albumin in DMEM (Gibco)] were then added, followed by an incubation period of 5 594 
min at 37°C. The mixture of solutions was then replaced by 160 μl of DMEM 595 
(Linaris) supplemented with 1 % insulin-transferrin-selenium X (Gibco) and 200 U/L 596 
penicillin-streptomycin (Gibco). The glands were triturated with a 200-μl pipette tip 597 
and the cell suspension was placed as 50 μl drops on coverslips in a 6-well plate. 598 
Following an incubation period of 30 min at 37°C at 8 % CO2 to allow cells to settle, 599 
2 ml of DMEM (Linaris) with the supplements described above were added per well 600 
and the cells were kept at 37°C and 8 % CO2. The cells were used for 601 
electrophysiological recordings on days in vitro 2-3.  602 
 603 
Viral constructs  604 
Expression constructs based on the SFV plasmid (pSFV1) for Munc13-1 and 605 
ubMunc13-2, both subcloned in frame with a C-terminal EGFP, have been described 606 
previously (Rosenmund et al., 2002). Munc13-4 and Baiap3 pSFV1 expression 607 
constructs were generated as IRES-EGFP constructs using the full-length mouse 608 
cDNAs. Production of SFV particles was done according to published protocols 609 
(Ashery et al., 1999). Briefly, pSFV1 constructs and pSFV-helper2 DNA were 610 
linearized with Spe I and transcribed into RNA using SP6 RNA polymerase. RNA 611 
from the pSFV1 constructs and the pSFV-helper2 construct, 10 μg each, were 612 
electroporated (500 V, 0.957 mF) into baby hamster kidney 21 cells. Supernatant of 613 
cell cultures containing the virus was collected after 24 h. In cases where the virus 614 
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titer was low, the supernatant was concentrated approximately 25-fold using a filter 615 
unit with a nominal molecular weight limit of 100 kDa (UFC910024, AMICON). 616 
SFV particles encoding the respective Munc13 isoforms with EGFP or only EGFP as 617 
a control were added to chromaffin cell cultures, infected cells identified based on the 618 
EGFP fluorescence, and electrophysiological recordings performed 4-6 h after 619 
addition of the virus. 620 
 621 
Whole-cell capacitance measurements 622 
Whole cell patch-clamping was performed with Sylgard-coated 4-6 MΩ pipettes 623 
(Science Products) at a setup equipped with a Zeiss Axiovert 200 microscope (Zeiss) 624 
and a HEKA EPC-10 amplifier controlled by Patchmaster (HEKA). Capacitance 625 
measurements were performed according to the Lindau-Neher technique using the 626 
„sine+dc“ mode in the Lockin Extension of Patchmaster. The frequency and peak-to-627 
peak amplitude of the sine wave were 1042 Hz and 70 mV, respectively, and the 628 
holding potential was -70 mV. Recordings were sampled at 12.5 kHz and filtered at 629 
2.9 kHz. Flash photolysis experiments were performed according to established 630 
protocols (Voets, 2000; Walter et al., 2010). The extracellular solution contained 147 631 
mM NaCl, 10 mM HEPES, 11.1 mM D-glucose, 2.8 mM KCl, 2 mM CaCl2, 1 mM 632 
MgCl2 and 3 μM tetrodotoxin (pH 7.2, 300-310 mOsM). For flash experiments, the 633 
intracellular solution contained 109 mM L-glutamic acid, 35 mM HEPES, 5 mM 634 
nitrophenyl-EGTA (Synaptic Systems), 5.65 mM CaCl2, 2 mM Mg-ATP, 0.3 mM 635 
Na-GTP, 0.205 mM fura-4F (Invitrogen), 0.3 mM furaptura (Invitrogen) and 1 mM 636 
ascorbic acid (titrated to pH 7.2 with CsOH, osmolarity 290-295 mOsM). The flash 637 
stimulus was applied approximately 80 s after the whole-cell configuration was 638 
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established using a xenon lamp (Rapp OptoElectronics). Unless otherwise specified, 639 
only cells with pre-flash [Ca2+] in the range of 300-600 nM were used for analysis. In 640 
flash photolysis experiments requiring pre-flash [Ca2+] concentrations higher than 600 641 
nM (Figure 7 and Figure 7–figure supplement 1), pulses of light at wavelengths of 642 
340 and 380 nm were applied at varying frequencies to release Ca2+ from nitrophenyl-643 
EGTA and the cell was kept at the target [Ca2+] for ∼20 s before the flash stimulus 644 
was given. The pre-flash [Ca2+] was taken as the averaged measured [Ca2+] during the 645 
20 s period. In depolarization experiments, the same extracellular solution was used 646 
except that tetrodotoxin was omitted. The intracellular solution contained 111 mM L-647 
glutamic acid, 35.5 mM HEPES, 17 mM NaCl, 1 mM MgCl2, 2 mM Mg-ATP, 0.3 648 
mM Na-GTP (titrated to pH 7.2 with CsOH, osmolarity 290-295 mOsM), and fura-4F 649 
and furaptra at the same concentration used in flash experiments. In flash photolysis 650 
experiments, pool sizes (fast and slow bursts) and their time constants were obtained 651 
by fitting a sum of exponential functions to the capacitance traces (Sorensen et al., 652 
2003b), using a custom macro (Three-Exponential-Fit-Macro-Igor) with the software 653 
IgorPro (WaveMetrics). The near-linear rate of release of the sustained component is 654 
measured as a linear component with the unit capacitance increase per second. The 655 
exocytotic delay was defined as the time point where the exponential fit meets the 656 
pre-flash capacitance.  657 
 658 
Ca2+ measurements 659 
In flash experiments, exocytosis was stimulated by a sudden elevation of intracellular 660 
[Ca2+] using UV flash stimuli given by a xenon flash lamp (Rapp OptoElectronics). 661 
[Ca2+] measurements were performed according to established protocols (Voets, 662 
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2000; Walter et al., 2010). The ratiometric Ca2+ indicator dyes fura-4F and furaptra 663 
were alternately excited at 340 and 380 nm using a Polychrome V monochromator 664 
(TILL Photonics), and the emitted light was detected with a photomultiplier. The area 665 
of fluorescence measurement was limited to the diameter of the cell. The 340/380 nm 666 
fluorescence ratio was independently calibrated at the same dye concentrations with a 667 
range of intracellular solutions with known [Ca2+], buffered with Ca2+ buffers 1,2-668 
bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA, Invitrogen) and 669 
diethylenetriaminepentaacetic acid (DPTA, Sigma-Aldrich). The [Ca2+] of the 670 
calibration solutions was calculated using KD of BAPTA = 0.222 μM and KD of 671 
DPTA = 80 μM. 672 
 673 
Amperometry 674 
Amperometric recordings were performed using carbon fibers of 5 µm diameter 675 
(Thornel P-650/42; Cytec, NJ, USA), insulated using the polyethylene method 676 
(Bruns, 2004). Vesicle fusion was triggered by infusing the cells through the patch 677 
pipette with a solution containing 4.6 µM free Ca2+. The fibers were clamped at 700 678 
mV and currents were hardware filtered at 3 kHz using an EPC-7 patch clamp 679 
amplifier (HEKA). Currents were digitized at 25 kHz and filtered off-line using a 680 
Gaussian filter with a cut-off set at 1 kHz. Filtering, spike detection, and analysis 681 
were performed using a freely available, custom-written macro (Mosharov and 682 
Sulzer, 2005) running under IgorPro (Wavemetrics, Lake Oswego, OR). A spike 683 
detection threshold of 5 pA and a foot detection threshold of 2 pA were imposed. For 684 
each analyzed cell, the median of each parameter (duration, halftime, amplitude, 685 
charge, rise time, decay time, foot amplitude, foot duration, foot charge) was 686 
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calculated from all spikes, and this value was used for averaging between cells 687 
(giving the mean of cell medians). 688 
 689 
High-pressure freezing of adrenal gland slices for EM analysis 690 
Adrenal glands from E18 animals were embedded in 3% low gelling agarose (Sigma-691 
Aldrich) and adrenal gland slices were prepared according to published protocols 692 
(Moser and Neher, 1997). Slices were allowed to recover in bicarbonate-buffered 693 
saline (125 mM NaCl, 26 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM 694 
CaCl2, 1 mM MgCl2, 10 mM D-glucose and 0.2 mM (+)-tubocurarine) at 37°C for 15 695 
min and were subsequently kept in the same solution at RT before cryofixation. Slices 696 
were rapidly frozen in external cryoprotectant (20% BSA in bicarbonate-buffered 697 
saline) using a HPM100 HPF device (Leica). After freezing, samples were stored in 698 
liquid nitrogen until further processing. Freeze substitution was performed as 699 
previously published (Rostaing et al., 2006). Briefly, samples were substituted in 700 
anhydrous acetone, fixed by 2% OsO4 in acetone for 7h at -90°C prior to a 701 
temperature ramp (5°C/h) to -20°C, an incubation for 16 h at -20°C, and a final ramp 702 
(10°C/h) to 4°C. Samples were washed in acetone and infiltrated with EPON resin at 703 
room temperature (acetone/EPON 1:1 for 3 h, 90% EPON in acetone overnight, and 704 
pure EPON for 36 h). Finally specimen carriers containing infiltrated samples were 705 
incubated for 24 h at 60°C to polymerize. Aluminum sample carriers were trimmed 706 
off the EPON block with a specimen trimming device (EM TRIM2, Leica) to expose 707 
the surface of the embedded tissue for ultramicrotomy. 708 
 709 
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Sectioning, contrasting, and fiducial marker application for EM 710 
An Ultracut UCT ultramicrotome (Leica) was used to cut 500 nm-thick sections until 711 
the first tissue appeared. Ultrathin (50 nm) and semithin (400 nm) sections were then 712 
collected onto Formvar-filmed, carbon-coated copper slot or mesh grids for 2D and 713 
3D ultrastructural analysis, respectively. Vitrified samples were subjected to rigorous 714 
quality control (Mobius et al., 2010) and samples exhibiting indications of ice-crystal 715 
damage were excluded from the analysis. Ultrathin sections were post-stained with 716 
1% uranyl acetate in ddH2O for 30 min, washed several times in ddH2O, stained with 717 
0.3% lead citrate for 2 min, washed, and dried with filter paper. For 3D-tomographic 718 
analysis, 400 nm-thick sections were briefly incubated in a solution of Protein A 719 
conjugated to 10 nm gold particles (Cell Microscopy Center, Utrecht, The 720 
Netherlands) to introduce fiducial markers. 721 
 722 
2D-EM analysis of chromaffin cells 723 
Electron micrographs (2048 x 2048 pixels) were acquired with a sharp:eye CCD 724 
camera (Tröndle, TRS) at 5,000 fold magnification using the multiple image 725 
acquisition and alignment feature of iTEM software (version 5.1, Olympus Soft 726 
Imaging Solutions GmbH). Assembled montages had dimensions of approximately 21 727 
x 21 µm and typically contained 1-3 randomly chosen chromaffin cells. Only 728 
chromaffin cells with a clearly visible plasma membrane were included in the 729 
analysis. iTEM software was used to measure chromaffin cell plasma membrane 730 
circumference and the cytoplasmic area (calculated by subtraction of the nuclear area 731 
from the total cell area). Additional parameters including the number of LDCVs and 732 
the shortest distance of each LDCV to the plasma membrane were quantified using 733 
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ImageJ software. In regions where the plasma membrane did not appear as a clear cut, 734 
the shortest distance from the vesicle membrane to the middle of the membrane 735 
projection was measured. For this reason and due to the fact that LDCVs (mean 736 
diameter of CTRL LDCVs ~ 160 nm; ~ 170 nm for docked CTRL LDCVs) might 737 
have their centers outside of the imaged ultrathin (50 nm) section, we did not quantify 738 
LDCV docking as defined by physical membrane-attachment in these 2D projection 739 
images, but rather calculated the number of membrane-proximal LDCVs (within 0-40 740 
nm of the plasma membrane). All vesicles with electron-dense cargo were included in 741 
the analysis. Secretory vesicles of both genotypes exhibited heterogeneity in size (see 742 
Figure 6–figure supplement 1) and appearance (e.g. compactness of the dense-core), 743 
possibly reflecting distinct LDCV types (e.g. adrenaline vs. noradrenaline) or 744 
different levels of maturity present in immature (E18) chromaffin cells. Data are 745 
presented as LDCV density (number of LDCVs per µm² area cytoplasm), the number 746 
of LDCVs within 40 nm of the plasma membrane normalized to the cell perimeter, 747 
and the mean frequency distribution of LDCVs from the plasma membrane in 40 nm 748 
bins. 749 
 750 
3D-EM analysis of LDCV docking in chromaffin cells 751 
For high-resolution electron tomographic analysis of LDCV docking in adrenal 752 
chromaffin cells, we randomly selected regions between two neighboring cells that 753 
exhibited a high density of LDCVs in proximity of the plasma membrane in thick 754 
(400 nm) sections. Single-axis tilt series were acquired from -60° to  +60° with 1° 755 
increments and binned by the factor two at 10,000 fold magnification using an Orius 756 
SC1000 camera (Gatan) and the SerialEM software for automated tilt series 757 
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acquisition (Mastronarde, 2005). Tomograms were reconstructed using the IMOD 758 
package (Kremer et al., 1996), and exported as z-stacks for analysis with ImageJ 759 
(National Institutes of Health). All analyses were performed blindly and manually. 760 
The smallest distance between the plasma membrane and the outer leaflet of each 761 
LDCV membrane was measured at its vesicular midline using the straight-line tool of 762 
ImageJ on individual virtual z-slices. Only vesicles observed in physical contact with 763 
the plasma membrane in tomographic volumes were considered ‘docked’. In 764 
distribution analyses docked LDCVs were assigned to the 0-4 nm bin to account for 765 
the voxel dimensions of reconstructed tomograms (isotropic voxel size = 2.86 nm). 766 
The number of membrane-attached (0-4 nm, ‘docked’) LDCVs identified in a 767 
tomographically reconstructed volume was normalized to the number of membrane-768 
proximal (0-40 nm of plasma membrane) LDCVs. The number of membrane-769 
proximal (0-40 nm) LDCVs was expressed as a percentage of all LDCVs within 100 770 
nm of the plasma membrane and compared across genotypes to test for potential 771 
differences in the ability of recruiting LDCVs close to the plasma membrane. The 772 
frequency distribution displays the number of docked LDCVs (0-4 nm, first bin) and 773 
subsequently the distances of LDCVs from the plasma membrane in 2 nm bins. 774 
Statistical analyses were performed using Student’s t-test. The mean LDCV diameter 775 
was calculated from the area of the LDCV measured at its midline including the 776 
vesicular phospholipid bilayer in electron tomograms by using the elliptical selection 777 
tool in ImageJ. All LDCVs in the randomly chosen field of view that contained their 778 
midline within the tomographic volume were analyzed (Figure 6–figure supplement 779 
1).  780 
 781 
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For illustrative purposes, figures depicting tomographic subvolumes represent an 782 
overlay of 3 consecutive slices produced by the slicer tool of the 3dmod software of 783 
the IMOD package to generate a ~ 8.6 nm thick subvolume.  784 
 785 
Calculation of the number of docked LDCVs per chromaffin cell 786 
The size of the pool of docked LDCVs per cell can be calculated from the number of 787 
LDCVs per µm² PM area (na) (Parsons et al., 1995; Plattner et al., 1997). We 788 
measured the number of membrane-proximal LDCVs (0-40 nm of PM) per µm PM 789 
length (nl) in ultrathin sections of 0.05 µm thickness. Our 3D-ET approach permitted 790 
us to accurately measure LDCV diameters (dv in µm) in chromaffin cells (Figure 6–791 
figure supplement 1). The number of LDCVs per µm² PM area could then be 792 
calculated as na = nl/(dv + 0.05) (Parsons et al., 1995; Plattner et al., 1997). The 793 
average cell surface area (ac in µm2) per genotype was estimated based on the average 794 
cell capacitance measured in cultured cells assuming 1 μF/cm2. We chose this 795 
method, rather than using the cell circumference measured in ultrathin sections, 796 
because the chromaffin cells in adrenal slices are not round, but have rather complex 797 
shapes (Figure 6–figure supplement 1). Using either measurement, the 798 
Unc13aKOUnc13bKO cells were slightly larger, by 5% based on capacitance, and by 799 
15% based on cell circumference measurements. 800 
Unc13aHetUnc13bHet  control cells: 801 
nl: 0.984 ± 0.075 vesicles per µm length 802 
dv: 0.1627 ± 0.005 µm vesicle diameter 803 
na: 4.627 vesicles per µm² PM area 804 
ac: 421.23 µm² cell membrane area 805 
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The estimated number of LDCVs within 40 nm of the PM in Unc13aHetUnc13bHet 806 
chromaffin cells is therefore ~ 1949. Our 3D analysis of LDCV docking revealed that 807 
only 33.97% of LDCVs within 40 nm of the PM are physically attached to the PM, 808 
therefore we estimated the pool of docked vesicles to contain ~ 662 LDCVs in our 809 
acute adrenal slice preparation. 810 
Unc13aKOUnc13bKO cells: 811 
nl: 1.150 ± 0.083 vesicles per µm length 812 
dv: 0.1525 ± 0.003 µm vesicle diameter 813 
na: 5.679 vesicles per µm² PM area 814 
ac: 442.26 µm² cell membrane area 815 
The estimated number of LDCVs within 40 nm of the PM in Unc13aKOUnc13bKO 816 
chromaffin cells is therefore ~ 2511. Our 3D analysis of LDCV docking revealed that 817 
only 34.43% of LDCVs within 40 nm of the PM are physically attached to the PM, 818 
therefore we estimated the pool of docked vesicles to contain ~ 865 LDCVs in our 819 
acute adrenal slice preparation. 820 
 821 
 Modeling the Ca2+-dependence of vesicle priming 822 
We simulated capacitance traces in Ca2+ uncaging experiments with an exocytosis 823 
model that was adapted from a previous study of ours (Walter et al., 2013) to 824 
explicitly describe the Ca2+ dependent vesicle priming reaction. Parameters (Table 1) 825 
were either taken from the literature, directly from experiments (Figure 7A), or 826 
determined by fitting the model to experimental capacitance traces. 827 
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We assume that Munc13 proteins act on the Ca2+-dependent priming reaction, which 828 
ensures the refilling of vesicles from a large depot pool (Voets, 2000). We wanted to 829 
explicitly describe this reaction in terms of its thermodynamic steady state binding 830 
properties (i.e. its dissociation constant KD and cooperativity n), and in terms of its 831 
Ca2+ binding kinetics. Let the chemical equation for Ca2+ binding to the priming 832 
sensor (PS) be: 833 
݊ ∗ ܥܽଶା + ܲܵ  (ܥܽ௡ ܲܵ) ೖ೚೑೑ርۛ ۛۛ ሲ
ೖ೚೙ሱۛ ሮ  
Then its overall dissociation constant KD is defined as: 834 
ܭ஽ = ൣ஼௔
మశ൧೙[௉ௌ]
[஼௔೙௉ௌ]   835 
In order to obtain the values of the ܭ஽ and n experimentally, we pre-equilibrated 836 
chromaffin cells at different pre-flash [Ca2+] prior to uncaging. The secretion 837 
responses were averaged in bins and normalized to their respective values 3 s after the 838 
flash. Fitting the fraction of release 30 ms after the uncaging stimulus as a function of 839 
pre flash [Ca2+] with the following Hill equation (non-linear curve fitting routine of 840 
Origin Pro 8 G, OriginLab Corporation) allowed us to estimate ܭ஽ and n: 841 
ܨݎܽܿݐ݅݋݊([ܥܽଶା]) = ൣ஼௔మశ൧
೙
௄ವା[஼௔మశ]೙ ܨ݉ܽݔ  842 
Where  ܨݎܽܿݐ݅݋݊([ܥܽଶା]) is the relative release at 30 ms, and [ܥܽଶା] is the pre-flash 843 
Ca2+ concentration. ܨ݉ܽݔ, n and ܭ஽ are free parameters. The best fit is shown as 844 
solid line in Figure 7 and the values of n and ܭ஽  can be found in Table 1. 845 
We assume that priming is only increased when the proper number (n) of Ca2+ ions 846 
are bound to the PS. Therefore, the rate of priming is proportional to the fraction (݂) 847 
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of PS that has bound the correct number of Ca2+ ions divided by the total amount of 848 
PS: 849 
݂(ܥܽଶା) = [ܥܽ௡ܲܵ][PS௧௢௧]  
݇ଵ(ܥܽଶା) = ݂(ܥܽଶା) ݇ଵெ௔௫ 
Where kଵெ௔௫ is the asymptotic value of the priming rate for [ܥܽଶା] ≫ ܭ஽. Since the 850 
total amount of PS is the sum of Ca2+-free and Ca2+-bound PS: 851 
݂(ܥܽଶା) = [ܥܽ௡ܲܵ][ܥܽ௡ܲܵ] + [PS] 
At steady state, the following relationships hold: 852 
݂(ܥܽଶା)ௌ௧௘௔ௗ௬ௌ௧௔௧௘ =
[ܥܽଶା]௡
ܭ஽ + [ܥܽଶା]௡ 
݇ଵௌ௧௘௔ௗ௬ௌ௧௔௧௘(ܥܽଶା) =
[ܥܽଶା]௡
ܭ஽ + [ܥܽଶା]௡  ݇ଵெ௔௫ 
In order to describe temporal changes in this fraction at non-equilibrium conditions, 853 
the Ca2+ concentrations ([ܥܽଶା]) were interpolated from the experimental values and 854 
the concentration of [ܥܽ௡ܲܵ] was calculated at all time points by numerical 855 
integration using the “ode15s” function in Matlab (version R2013a, Mathworks) of 856 
the kinetic equation: 857 
݀[ܥܽ௡ܲܵ]
݀ݐ =  ݇௢௡[ܲܵ][ܥܽ
ଶା]௡ − ݇௢௙௙[ܥܽ௡ܲܵ] 
We assume that the amount of PS is not limiting (i.e. that each vesicle contains a PS). 858 
Then, by investing the relationships 859 
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we obtain 861 
݀[ܥܽ௡ܲܵ]
݀ݐ =  ݇௢௡([V௧௢௧] − [ܥܽ௡ܲܵ]) [ܥܽ
ଶା]௡ − ܭ஽݇௢௡[ܥܽ௡ܲܵ] 
Such that the fraction of activated PS can be calculated at time t: 862 
݂(ܥܽଶା, ݐ) = [ܥܽ௡ܲܵ](ݐ)[V௧௢௧]  
 863 
This allows us to calculate ݇ଵ at all times t. 864 
 865 
݇ଵ(ܥܽଶା, ݐ) = ݂(ܥܽଶା, ݐ) ݇ଵெ௔௫ 
 866 
Our model consists of a sequence of mandatory steps for vesicle maturation and 867 
fusion (Walter et al., 2013). Vesicles from the depot enter a non-releasable state 868 
(NRP, Figure 7E) from which they cannot fuse directly. Instead, these vesicles first 869 
need to mature into the readily releasable pool (RRP), a transition that is governed by 870 
a Ca2+-dependent rate constant (k2(Ca2+)). This Ca2+-dependence is modeled by a 871 









As in our previous study, we assume that binding of one Ca2+ ion activates the 877 





ܭ஽,௖௔௧ + [ܥܽଶା] 
 881 
Kinetic equations of the exocytosis model 882 
݀[ܦ݁݌݋ݐ]
݀ݐ = −݇ଵ(ܥܽ
ଶା)[ܦ݁݌݋ݐ] + ݇ିଵ[ܴܰܲ] 
݀[ܴܰܲ]
݀ݐ = ݇ଵ(ܥܽ
ଶା)[ܦ݁݌݋ݐ] − ൫݇ିଵ + ݇ଶ(ܥܽଶା)൯[ܴܰܲ] + ݇ିଶ(ܥܽଶା)[ܴܴܲ] 
݀[ܴܴܲ]
݀ݐ = ݇ଶ(ܥܽ
ଶା)[ܴܰܲ] − (݇ିଶ(ܥܽଶା) + 3݇ଷ[ܥܽଶା])[ܴܴܲ] + ݇ିଷ[ܴܴܲܥܽ] 
݀[ܴܴܲܥܽ]
݀ݐ = 3݇ଷ[ܥܽ
ଶା][ܴܴܲ] − (݇ିଷ + 2݇ଷ[ܥܽଶା])[ܴܴܲܥܽ] + 2݇ିଷ[ܴܴܲܥܽଶ] 
݀[ܴܴܲܥܽଶ]
݀ݐ = 2݇ଷ[ܥܽ





ଶା][ܴܴܲܥܽଶ] − (3݇ିଷ + ݇ସ)[ܴܴܲܥܽଷ] 
݀[ܨ]
݀ݐ = ݇ସ[ܴܴܲܥܽଷ] 
 883 
Modeling of exocytosis upon Ca2+ uncaging  884 
To find the steady state occupation of the system ݇ଵ(ܥܽଶା), ݇ଶ(ܥܽଶା) and 885 
݇ିଶ(ܥܽଶା) were calculated for the experimental pre-flash Ca2+ values, the first five 886 
kinetic equations were taken and set to zero, and mass conservation of vesicles was 887 
obeyed: 888 
0 = [ܦ݁݌݋ݐ]଴ + [ܴܰܲ]଴ + [ܴܴܲ]଴ + [ܴܴܲܥܽ]଴ + [ܴܴܲܥܽଶ]଴ + [ܴܴܲܥܽଷ]଴
− [V௧௢௧] 
This system of 6 equations was solved using the function “fsolve” of Matlab (version 889 
R2013a, Mathworks). The steady state values were used as starting values for the 890 
numerical integration of the kinetic equations using the “ode15s” function of Matlab 891 
(version R2013a, Mathworks).  892 
For parameter optimization, model simulations were compared to experimental 893 
capacitance data. The parameters of the model were varied and the goodness of fit 894 
was determined in a cost function, which was the sum of squared deviations between 895 
data and model prediction. In order to avoid bias towards data with larger secretion, 896 
the cost function used relative deviations: deviations were normalized to the maximal 897 
value of either the experimental capacitance trace or the simulated one, whichever 898 






ଶ         ݂݋ݎ max (ݕா௫௣௘௥௜௠௘௡௧) < max(ݕெ௢ௗ௘௟) 
ܿ݋ݏݐ = ݓ݁݅݃ℎݐ(݅)max(ݕெ௢ௗ௘௟) ෍ ቀݕா௫௣௘௥௜௠௘௡௧(݅)௜
− ݕெ௢ௗ௘௟(݅)ቁ
ଶ             ݂݋ݎ max (ݕா௫௣௘௥௜௠௘௡௧) ≥ ݉ܽݔ (ݕெ௢ௗ௘௟) 
 900 
Three principal kinetic components have been described in capacitance traces: a fast 901 
component with a time constant of tens of milliseconds, a slower component with a 902 
time constant of hundreds of milliseconds and a sustained component with a time 903 
constant of several seconds (Voets, 2000). To account for the fact that more data 904 
points exist for slower components (due to the constant sampling rate) which would 905 
dominate the fit, deviations at shorter times after the uncaging flash were given larger 906 
weight: the weight was 100 for all datapoints upto 80 ms after the uncaging stimulus; 907 
the weight was 10 for all datapoints occurring later than 80 ms, but earlier than 1.2 s 908 
after the stimulus; the weight was 1 for all datapoints thereafter. To ensure 909 
consistency, all conditions depicted in Figure 7 were fitted simultaneously and the 910 
cost values from all data were summed. Only the parameters labeled with “best fit” in 911 
Table 1 were allowed to vary. Because the lowest bin of the capacitance traces of the 912 
DKO overexpressing Munc13-1 and ubMunc13-2 in Figure 7B and C contained 913 
relatively few cells, the total number of vesicles was also a free parameter under these 914 
conditions (best fit values Vtot(Munc13-1 low Ca2+)=2120 fF, Vtot(Munc13-1 low 915 
Ca2+)=3340 fF). All parameters were optimized by minimizing the cost values using a 916 
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Nelder-Mead Simplex algorithm implemented in the Matlab function “fminsearch” 917 
(version R2013a, Mathworks). 918 
 919 
Statistics 920 
Statistical analyses were performed using two-tailed Student’s t-test, ANOVA with 921 
post-hoc Tukey’s test, or Mann-Whitney U test as specified in the figure legends. 922 
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Figure legends 1213 
Figure 1.  1214 
Expression of Munc13 isoforms in the mouse adrenal gland. KO mouse lines of 1215 
the respective Munc13 isoform were used as control. The antibodies used to detect 1216 
individual Munc13 isoforms and loading controls are indicated on the left. (A) 1217 
Munc13-1 (*) is barely detectable in perinatal adrenal gland. (B) ubMunc13-2, but not 1218 
bMunc13-2, is expressed. (C) Munc13-3 was not detected. (D) Baiap3 was detected, 1219 
but not (E) Munc13-4. Jx refers to mice homozygous for the Unc13dJinx mutation 1220 
(Crozat et al., 2007). (F) Munc13-1 and Baiap3 are mainly located in the medulla 1221 
(Med), but ubMunc13-2 is present in cortex (Cort) as well. Please note that the 1222 
difference in the position of ubMunc13-2 relative to the marker in panels (B) and (F) 1223 
is due to how far the respective gels were run. Loading controls were valosin-1224 
containing protein (VCP), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 1225 
CgA. Brain samples, and spleen tissue in the case of Munc13-4, were used for 1226 
comparison. Please note that the Baiap3KO (Wojcik et al., 2013) and Unc13aKO 1227 
animals express truncated protein products, whereas the truncated product present in 1228 
the Unc13bKO (Cooper et al., 2012) is not shown here. Based on previous analyses of 1229 
the Unc13aKO and Unc13bKO mice (Augustin et al., 1999; Cooper et al., 2012; 1230 
Varoqueaux et al., 2002), the truncated Munc13-1 and Munc13-2 products are neither 1231 
functional, nor do they have a dominant-negative effect. The truncated Baiap3 1232 
product was not detected in adrenal gland, and its effect in the brain, where it can be 1233 
detected in young animals up to P21, is currently unknown (Wojcik et al., 2013). See 1234 
also Figure 1–figure supplement 1. 1235 
 1236 
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Figure 1–figure supplement 1.  1237 
Comparison of Munc13-1, Munc13-2, and Munc13-3 expression. (A) Adrenal 1238 
gland and brain homogenates from Unc13a-EYFP, Unc13b-EYFP, and Unc13c-1239 
EGFP knockin (KI) mice were probed using an antibody that recognizes the GFP-1240 
derived tags, which allowed us to compare expression levels of Munc13-1, 1241 
ubMunc13-2, bMunc13-2 and Munc13-3 with the same antibody. The two bands 1242 
detected in the Unc13b-EYFP KI brain sample represent ubMunc13-2 (lower band) 1243 
and bMunc13-2 (upper band). While all isoforms were detected in brain, ubMunc13-1244 
2-EYFP was the only isoform readily detectable in the adrenal gland. Valosin-1245 
containing protein (VCP) was used as a loading control. (B) Adrenal gland and brain 1246 
samples from Unc13aKOUnc13bKO (DKO) mice and WT controls, probed with 1247 
antibodies to Munc13-1, ubMunc13-2 and VCP as a loading control. Expression of 1248 
Munc13-1 (marked with *, to distinguish it from co-migrating bands of higher 1249 
molecular weight) is low in E18 adrenal glands, while ubMunc13-2 can be readily 1250 
detected. The expression of both isoforms was abrogated in DKO mice. Please note 1251 
that, like the single KO lines, the DKO animals express truncated Munc13-1 protein 1252 
products and a truncated Munc13-2 product (Cooper et al., 2012), the latter is not 1253 
shown here. 1254 
 1255 
Figure 2.  1256 
Flash photolysis induced LDCV exocytosis in chromaffin cells. For each KO line, 1257 
the average intracellular [Ca2+] ± SEM and the average ΔCm are shown in panels (A-1258 
C, and E). Single gene deletions of (A) Unc13a, (B) Unc13c, or (C) Baiap3 did not 1259 
impair LDCV exocytosis. (D) Summary of burst sizes, sustained release rates, and 1260 
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time constants. (E) LDCV exocytosis is dramatically reduced in Unc13aKOUnc13bKO 1261 
cells, Unc13aWTUnc13bKO cells, and Unc13aHetUnc13bKO cells. This reduction is 1262 
primarily due to the absence of ubMunc13-2. (F) Fast burst, slow burst and the rate of 1263 
sustained release are reduced in the absence of Munc13-1 and ubMunc13-2, as well as 1264 
in the absence of ubMunc13-2 alone (ANOVA with post-hoc Tukey’s test). (G) 1265 
Compared to Unc13aWTUnc13bKO cells, the deletion of Munc13-1 causes significant 1266 
reductions in the slow burst and the rate of sustained release (Student’s t-test, two-1267 
tailed). (H) Delay of the onset of exocytosis after the flash stimulus (ANOVA with 1268 
post-hoc Tukey’s test). (I) Normalized traces show identical release kinetics of the 1269 
exocytotic burst. (J) Summary of the release components shown in panels (E, F, G). 1270 
Time constants are not significantly different (ANOVA with post-hoc Tukey’s test). 1271 
(p < 0.05: *, p < 0.01: **, p < 0.001: ***). See also Figure 2–figure supplement 1. 1272 
 1273 
Figure 2–figure supplement 1.  1274 
Single gene deletion or overexpression of Baiap3 does not affect LDCV 1275 
exocytosis in chromaffin cells. (A) LDCV exocytosis was elicited by a series of 1276 
depolarizing steps to analyze the Immediately-Releasable Pool (IRP) of vesicles 1277 
localized in the vicinity of Ca2+ channels and the Readily-Releasable Pool (RRP). 1278 
Shown are the averaged [Ca2+] ± SEM, ΔCm, and whole-cell current traces. The inset 1279 
in the whole-cell current panel shows an enlargement of the first 100 ms 1280 
depolarization. (B) The size of the IRP, estimated based on the release elicited by 6 1281 
short (10 ms) depolarization pulses, was not altered. (C) The total ΔCm caused by the 1282 
depolarization train was also not altered in Baiap3KO cells. Note that the data from 1283 
Baiap3KO and Baiap3WT were matched for equal ionic influx according to the ionic 1284 
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charge of the first 100 ms depolarization to eliminate effects of differential ionic 1285 
influx. (D) Overexpression (OE) of Baiap3 in WT chromaffin cells. EGFP expression 1286 
in WT cells was used as control. Shown are the averaged [Ca2+] ± SEM and ΔCm 1287 
traces. (E) Burst sizes, rate of sustained release and the kinetics of release were not 1288 
altered by the overexpression of Baiap3 (Student’s t-test, two-tailed). (F) Normalized 1289 
traces of Baiap3WT and Baiap3KO cells overlapped with each other, indicating no 1290 
alterations in release kinetics in Baiap3KO cells. 1291 
 1292 
Figure 3.  1293 
Absence of Munc13-2 results in a significant release deficit in response to 1294 
depolarization. (A) Shown are the averaged [Ca2+] ± SEM, ΔCm, and whole-cell 1295 
current traces of Unc13bWT and Unc13bKO cells. The inset in the whole-cell current 1296 
panel shows an enlargement of the first 100 ms depolarization. (B) ΔCm elicited by 1297 
individual depolarizations was significantly different between the two groups. RRP, 1298 
Readily-releasable Pool; IRP, Immediately-Releasable Pool. (C) The size of the RRP 1299 
was measured as the ΔCm after the train of depolarization pulses and was 1300 
significantly reduced in Unc13bKO cells. (p < 0.05: *, p < 0.01: **, p < 0.001: ***; 1301 
Student’s t-test, two-tailed).   1302 
 1303 
Figure 4.  1304 
Reduced number of fusion events of catecholamine-containing LDCVs in the 1305 
absence of Munc13-2. (A) Illustration of a single amperometric spike, corresponding 1306 
to the release of catecholamines from a single LDCV, and the parameters analyzed. 1307 
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(B) Representative amperometric recordings of a Unc13bWT and a Unc13bKO cell. (C) 1308 
Dramatic reduction in spike frequency in Unc13bKO chromaffin cells. (D) Spike 1309 
duration, (E) width at half amplitude (t½), (F) maximum spike amplitude, (G) 1310 
amperometric charge, (H) rise time, and (I) decay time were unchanged in the 1311 
Unc13bKO. The stability of fusion pores was also not altered, as shown by the 1312 
unchanged (J) foot amplitude, (K) duration and (L) charge. (M) The fraction of 1313 
amperometric spikes with a detectable foot was reduced in Unc13bKO cells. (p < 1314 
0.05:*, p < 0.001:***; Student’s t-test, two-tailed). 1315 
 1316 
Figure 5. 1317 
LDCV exocytosis in Unc13aKOUnc13bKO chromaffin cells is rescued by 1318 
overexpression (OE) of Munc13-1, ubMunc13-2 and Munc13-4, but not Baiap3. 1319 
Unc13aKOUnc13bKO cells were infected with SFV-Munc13-1-EGFP, SFV-1320 
ubMunc13-2-EGFP, SFV-Munc13-4-IRES-EGFP or SFV-Baiap3-IRES-EGFP using 1321 
SFV-EGFP as control. (A) Averaged [Ca2+] ± SEM and capacitance traces ΔCm are 1322 
shown in the same graph to compare the efficiency of rescue: ubMunc13-2 > 1323 
Munc13-1 > Munc13-4 > Baiap3. (B) Burst sizes and rates of sustained release after 1324 
analysis of individual traces. (p < 0.05: *, p < 0.001: ***; Student’s t-test, two-tailed). 1325 
See Figure 5–figure supplement 1 for a direct comparison of Munc13-1-EGFP and 1326 
ubMunc13-2-EGFP expressing cell matched for fluorescence intensity and Figure 5–1327 
figure supplement 2 for Western blotting to confirm the expression of Munc13-4 and 1328 
Baiap3 from the IRES-constructs. 1329 
 1330 
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Figure 5–figure supplement 1. 1331 
Direct comparison of Munc13-1 and ubMunc13-2 over-expressing cells with 1332 
matching EGFP fluorescence. (A) Averaged [Ca2+] ± SEM and capacitance traces 1333 
ΔCm are shown in the same graph to compare the efficiency of rescue. (B) 1334 
Fluorescence intensity in arbitrary units (a.u.) of Unc13aKOUnc13bKO chromaffin 1335 
cells over-expressing Munc13-1-EGFP and ubMunc13-2-EGFP. (C) Expression of 1336 
ubMunc13-2 resulted in a significantly larger enhancement of burst size and rate of 1337 
sustained release than expression of Munc13-1. (p < 0.01: **, p < 0.001: ***; 1338 
Student’s t-test, two-tailed). 1339 
 1340 
Figure 5–figure supplement 2. 1341 
Western blot analysis confirming expression of Munc13-4 and Baiap3 SFV 1342 
constructs. Neuronal cultures were infected with SFV-Baiap3-IRES-EGFP and SFV-1343 
Munc13-4-IRES-EGFP, respectively. Tissue samples from Baiap3 and Unc13d (Jx) 1344 
WT and KO mice were used as controls. Both Baiap3 and Munc13-4 were expressed. 1345 
Please note, that we had to use infected neurons for this analysis, because our 1346 
chromaffin cell cultures do not provide enough material for Western blotting. 1347 
 1348 
Figure 6.  1349 
Ultrastructural analysis of LDCV docking in adrenal chromaffin cells. 2D-EM of 1350 
(A) Unc13aHetUnc13bHet (CTRL) and (B) Unc13aKOUnc13bKO (DKO) adrenal glands. 1351 
(C) Frequency distribution of LDCVs within 0-2 µm of the plasma membrane (PM). 1352 
(D) Membrane-proximal LDCVs (0-40 nm of PM) normalized to PM circumference. 1353 
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(E) Total number of LDCVs normalized to cytoplasmic area. (F-K) Tomographically 1354 
reconstructed subvolumes from 400 nm-thick sections through (F-H) 1355 
Unc13aHetUnc13bHet and (I-K) Unc13aKOUnc13bKO cells in which docked LDCVs 1356 
(enlarged in panels G, J) and undocked LDCVs (enlarged in panels H and K, small 1357 
gaps separating undocked LDCVs from the PM indicated with arrowheads) can be 1358 
distinguished. (L) Frequency distribution of membrane-proximal LDCVs distributed 1359 
within 0-40 nm of the PM. (M) Number of membrane-proximal LDCVs expressed as 1360 
a percentage of all LDCVs within 0-100 nm of the plasma membrane. (N) Percentage 1361 
of docked LDCVs with respect to all membrane-proximal LDCVs (within 0-40 nm of 1362 
PM). Scale bars represent 1 µm in (A, B), 200 nm in (F, I), and 50 nm in (H, K). C: 1363 
5779 LDCVs in CTRL and 4120 LDCVs in DKO profiles. D, E: CTRL: N=2, n=36; DKO: 1364 
N=2; n=27. L: 473 LDCVs in CTRL and 386 LDCVs in DKO tomographic subvolumes. 1365 
M, N: CTRL: N=2, n=24;DKO: N=2, n=26. Values indicate mean ± SEM. (Student’s t-1366 
test, two-tailed). See also Figure 6–figure supplement 1. 1367 
 1368 
Figure 6–figure supplement 1.  1369 
Ultrastructural analysis of LDCV size in adrenal chromaffin cells. 2D-EM of (A) 1370 
Unc13aHetUnc13bHet (CTRL) and (B) Unc13aKOUnc13bKO (DKO) adrenal glands. (C) 1371 
Frequency distribution of LDCV diameters measured by 3D-ET. (D) Mean LDCV 1372 
diameter in randomly imaged chromaffin cell areas. (E) LDCV diameter of docked 1373 
(0-4 nm of PM) vesicles. Scale bar in B represents 5 µm. C: 846 LDCVs in CTRL and 1374 
831 LDCVs in DKO tomographic subvolumes. D: CTRL: N=2, n=24; DKO: N=2, 1375 
n=26. E: CTRL: N=2, n=98; DKO: N=2, n=140. Values indicate mean ± SEM. 1376 
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(Student’s t-test, two-tailed; diameters of docked LDCVs were tested with Mann-1377 
Whitney U test). 1378 
 1379 
Figure 7.  1380 
Munc13-1 and ubMunc13-2 accelerate upstream vesicle priming (“priming step 1381 
1”) with identical Ca2+ affinities, but distinct rates. (A) Estimation of steady-state 1382 
Ca2+ affinities of vesicle priming driven by Munc13-1 or ubMunc13-2. Left two 1383 
panels: binned and averaged secretory responses in Unc13aKOUnc13bKO cells 1384 
overexpressing (OE) either Munc13-1 (green) or ubMunc13-2 (blue). The release 1385 
fraction at 30 ms (traces normalized to their amplitude after 3 s) after the stimulus was 1386 
determined as the read-out for priming (vertical broken lines). Right panel: the 1387 
fraction of release plotted as a function of pre-flash [Ca2+]. Both genotypes are 1388 
described by the same Hill function, suggesting a similar Ca2+-dependence of priming 1389 
(i.e. identical cooperativity and affinity). (B) Fits of a secretion model (see panel E) to 1390 
the capacitance responses observed experimentally in Unc13aKOUnc13bKO cells 1391 
expressing Munc13-1 at intermediate and low pre-flash [Ca2+]. Top panel: measured 1392 
Ca2+ values were used to drive the secretion model. The chemical equation shows a 1393 
priming sensor (PS), which is active in the Ca2+ bound state (CanPS). The lower panel 1394 
shows the experimental capacitance data (solid lines) together with simulations with 1395 
the best fit parameters (broken lines; see Table 1). Insert: magnified view with 1396 
horizontal/vertical scale bars: 200 ms/200 fF. (C) Same as (B), but for 1397 
Unc13aKOUnc13bKO cells expressing ubMunc13-2. The secretion model was fitted 1398 
using identical KDs and n for the Ca2+ binding to the PS (determined by the analysis 1399 
shown in panel A). The best-fit values suggest a ∼2.5-fold slower on-rate (activation 1400 
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rate), but a 4.5-fold higher maximal priming rate for ubMunc13-2 (see Table 1), 1401 
resulting in a sigmoidal secretion response from low pre-flash [Ca2+]. (D) Fitting our 1402 
secretion model to the experimental data of several genotypes suggests that Munc13-1 1403 
and ubMunc13-2 both primarily act by increasing the forward priming rate (k1, see 1404 
also panel E), while loss of ubMunc13-2 – the dominant endogenous isoform – has 1405 
the opposite effect. The downstream priming step (“priming 2”, k2) changes in the 1406 
opposite direction. (E) Secretion model: Munc13-1 (green) and ubMunc13-2 (blue) 1407 
regulate the Ca2+ binding rates (kon) to a PS, which controls the asymptotic forward 1408 
priming rate k1 (see text for details, Table 1 for fitted parameters, and Walter et al., 1409 
2013 for model development). NRP: Non-Releasable Pool; RRP: Readily-Releasable 1410 
Pool; F: Fused pool. See also Figure 7–figure supplement 1. 1411 
 1412 
Figure 7–figure supplement 1.  1413 
Exocytotic burst size as a function of pre-flash [Ca2+]. Unc13aKOUnc13bKO cells 1414 
were rescued by Munc13-1 or ubMunc13-2 overexpression (OE). For ubMunc13-1415 
2, data from 23 cells already analyzed for Figure 5 were included here as well. The 1416 
average size of the exocytotic burst is plotted as the ΔCm 0.5 s after the flash stimulus 1417 
± SEM against average pre-flash [Ca2+] ± SEM. Cells were binned according to pre-1418 
flash [Ca2+]. For Munc13-1, bins are 250-350 nM (n = 17), 350-450 nM (n = 15), 1419 
450-550 nM (n = 11), 550-800 nM (n = 11), 800-1200 nM (n = 13), 1200-1700 nM (n 1420 
= 7). For ubMunc13-2, bins are 250-350 nM (n = 11), 350-450 nM (n = 20), 450-540 1421 




Table 1. Parameters of the exocytosis model. 1425 























binding to PS 















k2  (Walter et al., 2013) 
k-2  (Walter et al., 2013) 
g(Ca2+) 
ܥܽଶା
ܥܽଶା + ܭ஽,௖௔௧ 
(Walter et al., 
2013) 
k20 2.37*10-2 s-1 2.95*10-2 s-1 1.29*10-2 s-1 5.80*10-3 s-1 Best fit 
k2cat 3.95*101 s-1 4.91*101 s-1 2.14*101 s-1 9.65*100 s-1 Best fit 
k-20 2.10*10-2 s-1 Best fit 
k-2cat  (Walter et al., 2013) 
KD, cat 138 µM Best fit 
k3 4.4 s-1μM-1 (Voets, 2000) 
k-3 56 s-1 (Voets, 2000) 




20 2(Ca ) catk g k= + ⋅
2+
20 2(Ca ) catk g k− −= + ⋅
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Unc13b      (n = 21)
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Amplitude at 0.5 s after flash 
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2D Analysis: Ultrathin Sections
Man et al. Figure 6
3D Analysis: Tomography
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